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Abstract
Background: Generalized anxiety and depression are extremely prevalent and de-
bilitating. There is evidence for age and sex variability in symptoms of depression,
but despite comorbidity it is unclear whether this extends to anxiety symptoma-
tology. Studies using questionnaire sum scores typically fail to address this pheno-
typic complexity.
Method: We conducted exploratory and confirmatory factor analyses on General-
ized Anxiety Disorder (GAD‐7) and Patient Health Questionnaire (PHQ‐9) items to
identify latent factors of anxiety and depression in participants from the Genetic
Links to Anxiety and Depression Study (N = 35,637; 16–93 years). We assessed age‐
and sex‐related variability in latent factors and individual symptoms using multiple
logistic regression.
Results: Four factors of mood, worry, motor, and somatic symptoms were identified
(comparative fit index [CFI] = 0.99, Tucker–Lewis Index [TLI] = 0.99, root mean
square error of approximation [RMSEA] = 0.07, standardized root mean square re-
siduals [SRMR] = 0.04). Symptoms of irritability (odds ratio [OR] = 0.81) were most
strongly associated with younger age, and sleep change (OR = 1.14) with older age.
Males were more likely to report mood and motor symptoms (p < .001) and females
to report somatic symptoms (p < .001).
Conclusion: Significant age and sex variability suggest that classic diagnostic criteria
reflect the presentation most commonly seen in younger males. This study provides
avenues for diagnostic adaptation and factor‐specific interventions.
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1 | INTRODUCTION
Major depressive disorder (MDD) and generalized anxiety disorder
(GAD) are the most common psychiatric disorders worldwide (Kessler
et al., 2005; Lim et al., 2018). Around 11% of the world's population
experience clinically relevant symptoms within their lifetime (Lim
et al., 2018) and they co‐occur simultaneously or sequentially in
50%–80% of cases (Brown et al., 2001; Jacobson & Newman, 2017;
Kroenke et al., 2007; Moffitt et al., 2007). MDD and GAD are het-
erogeneous conditions, meaning affected individuals can present
with unique symptom combinations (Fried & Nesse, 2015a, 2015b).
In research, questionnaire‐derived sum scores are commonly used to
identify cases or measure disorder severity (Fried & Nesse, 2015b;
Jokela et al., 2019; Ohannessian et al., 2017). Sum scores are a
symptom count, which assumes all symptoms equally and con-
sistently contribute to a disorder (Fried & Nesse, 2015b). They also
lack information on which symptoms are present for an individual and
how those symptoms interact (Jokela et al., 2019). For instance, four
underlying factors of generalized anxiety and depressive symptoms
were identified in the UK Biobank: anxiety symptoms, psychomotor‐
cognitive impairment, neurovegetative states, and mood symptoms
(Jermy et al., 2020). Exploring patterns of symptom co‐occurrence
instead of using sum scores may identify diagnostic subtypes of
MDD, GAD, or their comorbid presentation, helping to refine diag-
noses (Eeden et al., 2019).
The presentation of MDD symptoms varies across ages
(Schaakxs et al., 2017). Older people have been shown to more often
report somatic symptoms (Hegeman et al., 2012; Miloyan &
Pachana, 2016; Schaakxs et al., 2017; Zhao et al., 2018). However,
the age‐dependent presentation of symptoms is difficult to detect
using questionnaire‐derived sum scores. While depression sum
scores remain consistent across adulthood, older people are more
likely to report fatigue, psychomotor agitation, and sleep problems,
whereas younger people are more likely to report irritability, con-
centration problems, and anxiety (Schaakxs et al., 2017). Similarly,
endorsement of depression symptoms can vary by sex. Women are
more likely to endorse somatic symptoms of fatigue, muscle tension,
sleep problems, and appetite problems, whereas men are more likely
to endorse suicidal ideation (Fried et al., 2014; Vesga‐López
et al., 2008). It is unclear whether symptom level age and sex varia-
bility extends to GAD symptomology. Given the use of brief mea-
sures of generalized anxiety and depression symptoms as the criteria
for entry into the UK NHS Improving Access to Psychological
Therapies (IAPT) service, it is important to understand how symptom
presentations assessed by these measures might vary with age
and sex.
1.1 | Aims
In the present study, we aim to (a) identify latent factors composed of
MDD and GAD symptoms in participants from the Genetic Links to
Anxiety and Depression (GLAD) Study and (b) assess how individual
MDD and GAD symptoms and our identified factors were associated
with age and sex.
2 | METHODS
2.1 | Study design
The GLAD Study is an ongoing study of anxiety and depression
(Davies et al., 2019). Participants are recruited via an online platform
from the general population and National Health Service organiza-
tions. Individuals above 16 years of age, living in the United Kingdom
who have experienced depression or any anxiety disorder including
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GAD, social anxiety disorder, panic disorder, agoraphobia, social
phobia, and specific phobia are eligible. Participants complete the
online questionnaire and donate a saliva sample. All participants
provided full consent to take part and to the long‐term storage of
their data. Ethical approval was obtained from the London‐Fulham
Research Ethics Committee (REC reference: 18/LO/1218).
2.2 | Participants
Our analyses included 35,637 individuals who completed the online
questionnaire before May 19, 2020 and had no missing data on age,
sex, Generalized Anxiety Disorder (GAD‐7), or Patient Health Ques-
tionnaire (PHQ‐9). Participants reported their biological sex, ethni-
city, highest education level, and mental health diagnoses. Age
divided by 10 was used in analyses to aid odds ratio (OR) inter-
pretation. Participants’ age ranged from 16 to 93 years, with a mean
of 38.1 years (SD = 14.4). The majority of the sample was female
(79.6%), White (94.3%), and highly educated (Table 1). Overall, 88.2%
of participants self‐reported an MDD diagnosis and 76.6% a GAD
diagnosis.
2.3 | Measures
2.3.1 | Depression and generalized anxiety
symptoms
We measured current MDD symptoms with the PHQ‐9 (nine items;
Kroenke et al., 2001, 2010) and current GAD symptoms with the
GAD‐7 (seven items; Spitzer et al., 2006). These are commonly used
self‐report scales based on the Diagnostic and Statistical Manual of
Mental Disorders, 5th Edition (DSM‐5) diagnostic criteria (American
Psychiatric Association, 2013). For both scales, individuals rated the
frequency of symptoms experienced over the past 2 weeks. Items
were rated on a four‐point Likert‐type scale with scores ranging from
0 (not at all) to 3 (nearly every day). All item scores were summed to
create a severity sum score, with values ranging from 0 to 27 for the
PHQ‐9 and 0 to 21 for the GAD‐7. Both scales were psychome-
trically valid with high test–retest reliability (GAD: r = .83; PHQ:
r = .84), and internal consistency (GAD: alpha = .89; PHQ: alpha = .83;
Löwe et al., 2008; Spitzer et al., 2006; Thorp et al., 2019).
2.4 | Statistical analyses
2.4.1 | Exploratory and confirmatory factor analyses
Polychoric correlation matrices were computed for all ordinal items
(Holgado–Tello et al., 2008). To check for singularity/multicollinearity
of items, the matrix was examined for values <0.30 and >0.90. The
matrix determinant, Bartlett's Test of Sphericity (Bartlett, 1950),
Ordinal alpha (Gadermann et al., 2012), and the Kaiser–Meyer–Olkin
(KMO) statistic (Kaiser, 1974) were computed to assess whether the
data were fit for exploratory factor analysis (EFA). Parallel analysis
(Horn, 1965), Very Simple Structure (VSS; Revelle & Rocklin, 1979),
and Velicer's Minimum Average Partial (MAP) criterion (Velicer, 1976)
estimated the preliminary number of factors. See Supporting In-
formation Material A and B.
'EFA was performed in 70% of the sample using the weighted least
squares method in the “psych” R package (Revelle, 2017), which is pre-
ferred for ordinal data (Forero et al., 2009; Lee et al., 2012). Factors were
allowed to correlate using oblimin rotation. The following fit criteria in-
dicated good fit: root mean square error of approximation (RMSEA)≤
0.05, Tucker–Lewis Index (TLI)≥0.95, standardized root mean square
residuals (SRMR)≤0.05, and a smaller Bayesian Information Criterion
(BIC) relative to other models (Hu & Bentler, 1999). Items were retained
in a factor for factor loadings of >0.3 and greater than loadings on all
other factors. Where multiple models showed adequate fit, the model
with factors that encompass the greatest number of items was chosen.
To validate the EFA‐derived model, confirmatory factor analysis (CFA)
was conducted in the remaining 30% of the sample using the “lavaan” R
package (Rosseel, 2012). Standardized fit statistics were interpreted (Hu
& Bentler, 1999; Schreiber et al., 2006) and the comparative fit index
(CFI)≥0.95 was considered good fit. The CFA was computed in the full
sample to provide overview fit statistics.
Two sensitivity analyses were conducted. First, items with a low
loading (~0.3) on all factors were sequentially removed. If item re-
moval did not substantially improve model fit, the item was retained.
Second, the final model was computed for males and females sepa-
rately to assess sex differences in factor structure.
2.4.2 | Age and sex‐related variability generalized
anxiety and depression
We conducted three sets of regression analyses with age and sex.
First, we fitted linear regressions associating age/10 with PHQ‐9 and
GAD‐7 sum scores while controlling for sex. Each item was trans-
formed into a binary variable to indicate the presence or absence of
the symptom; 0 was coded as no symptom, and 1–3 were coded as
symptom present. Second, we fitted logistic regressions associating
dichotomized symptoms with age per 10 years and sex. Sum scores
were also controlled for, to assess only the occurrence of the in-
dividual symptom and account for cumulative symptom disorder
severity (Schaakxs et al., 2017). For age, an OR > 1 indicated an as-
sociation with being 10 years older and OR < 1 indicated an asso-
ciation with being 10 years younger. For sex, OR > 1 indicated an
association with being female while an OR < 1 indicated an associa-
tion with being male. Third, we regressed the CFA‐derived factor
scores on age and sex controlling for disorder severity, to identify
symptom groups that may vary across age and between the sexes.
To investigate nonlinear relationships between age and gen-
eralized anxiety/depression symptoms, logistic regression models
were computed using categorical age. Age was categorized into year
groups of 16–23, 24–31, 32–39, 48–55, 56–63, and >64 to avoid a
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TABLE 1 Demographic characteristics
of the Genetics Links to Anxiety and
Depression (GLAD) sample (N = 35,637)
Male (N = 7265) Female (N = 28372) Total (N = 35637)
N % N % N %
Age
Mean (SD) 43 (14.58) 37 (14.16) 38 (14.41)
Min 16 16 16
Max 93 93 93
Age‐group
16–25 years 1031 2.89 7210 20.23 8241 23.12
26–35 years 1582 4.44 7749 21.74 9331 26.18
36–45 years 1515 4.25 5162 14.48 6677 18.73
46–55 years 1633 4.58 4734 13.28 6367 17.86
56–65 years 1044 2.93 2637 7.40 3681 10.33
66–75 years 403 1.13 800 2.24 1203 3.37
76–85 years 52 0.15 74 0.21 126 0.36
86–95 years 5 0.01 6 0.02 11 0.03
Ethnicity
White 6856 19.24 26781 75.15 33637 94.39
Mixed 138 0.39 743 2.08 881 2.47
Asian or Asian British 114 0.32 359 1.01 473 1.33
Black or Black British 32 0.09 143 0.40 175 0.49
Arab 8 0.02 25 0.07 33 0.09
Other 91 0.26 254 0.71 345 0.97
Highest education level
GCSE/CSE 919 2.58 3385 9.50 4304 12.08
NVQ 690 1.94 2293 6.43 2983 8.37
A‐levels 1463 4.11 6520 18.30 7983 22.41
University 3876 10.88 15114 42.41 18990 53.29
Self‐reported diagnosis
MDDa 6374 17.89 25037 70.26 31411 88.15
MDD onlyb 800 2.24 2915 8.18 3715 10.42
GADa 5158 14.47 22143 62.13 27301 76.60
GAD onlyb 211 0.59 1030 2.89 1241 3.48
Anxiety disordera 2121 5.95 8658 24.29 10779 30.24
Anxiety disorder onlyb 2027 5.69 8187 22.97 10214 28.66
Abbreviations: CSE, certificate of secondary education; GAD, generalized anxiety disorder; GCSE,
general certificate of secondary education; MDD, major depressive disorder; NVQ, national vocational
qualification.
aIndividuals who reported the diagnosis regardless of comorbidities.
bIndividuals who only reported that diagnosis with no comorbidities.
4 | THOMPSON ET AL.
reduction in power. The middle group of 40–47 years was used as
the reference group. Two post hoc sensitivity analyses were con-
ducted. First, individuals who participated during the COVID‐19
pandemic were excluded at three intervals: January 31, 2020 (first
UK case; N = 2456), March 1, 2020 (higher awareness; N = 1222), and
March 23, 2020 (first UK lockdown; N = 342). Second, regression
analyses were replicated accounting for highest education level as a
proxy for socioeconomic status in the model.
The false discovery rate (FDR) multiple testing correction was
applied to all symptom and factor level analyses separately (Benjamini
& Hochberg, 1995; see Supporting Information Material C). All ana-




The item “Worrying too much about different things” was excluded from
EFA due to a polychoric correlation of 0.92 with the item “Difficulty
controlling worrying.” For information on item endorsement and corre-
lation structure, see Supporting Information Material D. EFA in 70% of
the sample (N=24,946) showed a four‐factor solution best fit the data
(Table 2). The RMSEA was slightly above the recommended threshold
(Hu & Bentler, 1999). All other fit statistics indicated good model fit. All
factors included two to five items, factor correlations ranged from 0.42 to
0.72 and the four‐factor model explained 70% of the variance in the data.
We labeled the four factors according to the loaded items: mood, worry,
somatic, and motor symptoms (Figure 1). Factors did not neatly split into
GAD and MDD symptoms, for example, motor symptoms contained one
symptom from both the PHQ‐9 and GAD‐7. Five and six‐factor models
showed slightly better fit; however, these solutions were unsuitable as
they included factors with zero items given the loading cut‐off of 0.3. See
Table S1 for EFA results with all items.
3.1.1 | EFA sensitivity analyses
Concentration problems and subsequently irritability (items with the
lowest loadings) were dropped from the EFA in an attempt to im-
prove model fit. This solution then showed only a very slight im-
provement, thus the full model was retained (Table S2). This model
was then fitted separately in males and females to check for sex
differences in factor loadings. In males, the concentration problems
item loaded onto the somatic symptoms factor rather than the mood
factor as seen in the full and female only model (Figure S5).
3.2 | CFA
The CFA model is predefined to that identified by EFA, which pro-
vides a more stringent test of model fit compared with EFA
(Thompson, 2004). The CFA in the remaining 30% of the sample
(N = 10,691) confirmed that the four‐factor model fit the data well.
The RMSEA (0.068, 95% confidence interval [CI]: 0.067, 0.091) was
still slightly above the threshold for good fit (Hu & Bentler, 1999),
although lower than that for the EFA. The TLI (0.993), CFI (0.994),
and SRMR (0.046) all indicated good fit (Hu & Bentler, 1999). The
CFA was then rerun in the full sample to provide an overall model
(CFI = 0.99, TLI = 0.99, RMSEA = 0.07, SRMR = 0.04). Factor scores
for each individual were computed from this final model and used in
the latent factor regression analyses.
3.3 | Age and sex‐related variation in generalized
anxiety and depression
3.3.1 | Sum scores
Women reported higher depression and generalized anxiety sum
scores compared with men. When controlling for sex, age was
TABLE 2 Model fit statistics for
exploratory factor analysis of one to six
factors in the Genetic Links to Anxiety and


















1 90 0.175 [0.174, 0.176] 0.736 67,991 0.09 0.56 15
2 76 0.126 [0.125, 0.127] 0.863 29,469 0.05 0.63 6
3 63 0.104 [0.102, 0.105] 0.907 16,359 0.04 0.67 0
4 51 0.076 [0.075, 0.078] 0.950 6907 0.02 0.70 2
5 40 0.055 [0.053, 0.057] 0.974 2665 0.02 0.72 0
6 30 0.040 [0.038, 0.042] 0.986 931 0.01 0.74 0
Note: The cut off for each statistic to signify “good” fit is listed in each header (Hu & Bentler, 1999).
The model with the lowest BIC is preferred. Cumulative variance is given as an indicator of the
variance explained between items by the number of factors in each model. The best fitting and chosen
model is indicated in bold.
Abbreviations: BIC, Bayesian information criterion; df, degrees of freedom; RMSEA, root mean square
error of approximation; SRMR, standardized root mean square residuals; TLI, Tucker–Lewis fit index.
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significantly associated with a 0.95 lower PHQ‐9 (p < .001) and a 0.98
lower GAD‐7 sum score (p < .001).
3.3.2 | Individual symptoms
Eight symptoms were associated with younger age and four with older
age, when controlling for sex, generalized anxiety severity and depression
severity (Figure 2a). Irritability and suicide ideation were most strongly
associated with younger age, followed by restlessness, weight/appetite
problems, motor problems, little energy, feeling anxious, and concentra-
tion problems. Sleep change was most strongly associated with older age,
followed by difficulty controlling worrying, worrying too much and
trouble relaxing. See Table S3 for full OR and CI values.
More symptoms were associated with being male than female
(Figure 2a). Weight/appetite problems, little energy, sleep change,
difficulty controlling worrying, and worrying too much were more
likely endorsed by females, while suicide ideation, anhedonia, de-
pressed mood, restlessness, worthlessness, concentration problems,
and motor problems were more likely endorsed by males. See
Table S3 for full OR and CI values.
These associations were replicated using categorical age groups.
Categorical age measurement also identified symptom occurrence
that cannot be captured by continuous age. Individuals who were
16–23 or over 64 years were less likely to report concentration
problems, little energy, trouble relaxing, weight or appetite problems
and worthlessness (Figure S6). This suggests a nonlinear relationship,
where individuals of middle age are more likely to report these
symptoms.
3.3.3 | Latent factors
Table 3 displays age and sex associations with each symptom cate-
gorized by the four corresponding factors. When controlling for sex,
generalized anxiety severity and depression severity, younger age per
10 years was significantly associated with 0.008 lower motor
symptoms (p < .001), and with 0.003 lower somatic symptoms
(p < .001; Figure 2b). When controlling for age, generalized anxiety
severity and depression severity, males were more likely to report
mood (β = −.04, p < .001), and motor symptoms (β = −.02, p < .001),
while females were more likely to report somatic symptoms (β = .06,
p < .001; Figure 2b).
As expected, the derived factor scores were highly correlated
with GAD‐7 and PHQ‐9 sum scores (Figure S7). In post hoc sensi-
tivity analyses, regressions were computed without controlling for
GAD‐7 and PHQ‐9 severity sum scores. We observed similar asso-
ciations for sex, but younger age was associated with all factors
(Figure S8). This is likely due to the over‐representation of younger
individuals in the GLAD sample; thus, the original model was retained.
3.4 | Post hoc sensitivity analyses
Neither excluding participants who had answered either the
GAD‐7 or the PHQ‐9 during the pandemic nor including educa-
tional attainment as a covariate led to a substantial change of
any of our results as effect sizes across models were highly
similar and confidence intervals overlapped (for details,
see Tables S4–S12).
F IGURE 1 Exploratory factor analysis of GAD‐7 and PHQ‐9 items in the Genetic Links to Anxiety and Depression (GLAD) Study (N = 35637;
15 items). (a) The path diagram, item factor loadings, and between‐factor correlations for the four factors of worry symptoms, mood symptoms,
somatic symptoms, and motor symptoms are shown. (b) The loading strength for every item on each of the identified factors are shown. Dark
blue indicates a positive factor loading, white indicates no factor loading, and red indicates a negative factor loading. GAD‐7, Generalized
Anxiety Disorder; PHQ‐9, Patient Health Questionnaire
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4 | DISCUSSION
Generalized anxiety and depressive symptoms in 35,637 GLAD par-
ticipants were represented by a four‐factor model of mood, worry,
somatic, and motor symptoms that varied by age and sex. The mood
factor was associated with being male, with corresponding symptoms
of suicide ideation and concentration problems more likely reported
by younger men. The motor factor and corresponding symptoms
were also more likely reported by younger men. The worry factor
showed no association with age or sex. However, its corresponding
symptoms of feeling anxious and irritable were more often reported
by younger participants, trouble relaxing by older participants, and
difficulty controlling worrying by older women. The somatic factor
was associated with being young and female, consistent with its
symptoms of little energy and weight/appetite problems. However,
sleep change was more likely to be reported by older women. Overall,
individual symptoms provide more information on age variation in
symptom occurrence, whereas sex variation is apparent across both
individual symptoms and factors.
Similar to previous work on generalized anxiety and depressive
symptomatology (Ballard et al., 2018; Beard & Björgvinsson, 2014;
Clark & Watson, 1991; Kertz et al., 2013), our four‐factor model
demonstrates that these are not two distinct underlying constructs.
Importantly, we replicated the generalized anxiety and depression
factor structure identified in the UK Biobank (Jermy et al., 2020) in a
separate, large, and clinically relevant cohort. Thus, our findings de-
monstrate the need to address the appropriateness of current diag-
nostic classifications. One difference between our findings and those
from the UK Biobank was that they found concentration problems
loaded onto the motor factor; we found this for men only. This could
suggest two things: First, there are sex differences in the occurrence
of concentration problems and the GLAD Study factor representation
reflects a more female picture of generalized anxiety and depression.
Second, a cognitive factor of depression and/or generalized anxiety
symptomatology may exist that is not captured by the questions
comprising both the PHQ‐9 and the GAD‐7 (LeMoult & Gotlib, 2019).
Our study replicates research that shows variation in depression
symptoms across age and sex, that is not captured by sum scores
(Fried et al., 2014; Schaakxs et al., 2017), and extends this by pro-
viding evidence for similar trends in generalized anxiety symptoma-
tology. Men were more likely to report all motor and mood
symptoms. This includes the two main DSM‐5 MDD symptoms of
depressed mood and anhedonia, which suggests that classic diag-
nostic criteria reflect presentation most commonly seen in younger
men. One contributor could be that men are more likely to have
lower perceived social support than women, which has been asso-
ciated with higher risk of anhedonia, depressed mood, worthlessness,
and suicidal ideation (Jokela et al., 2019). In our study, women were
F IGURE 2 Age‐ and sex‐related variation in generalized anxiety and depression in the Genetic Links to Anxiety and Depression (GLAD study;
N = 35,637). (a) Odds ratios (OR) and 95% confidence intervals (CI) for the association between all GAD‐7 and PHQ‐9 items and age (per 10 years)
in blue and sex in yellow are shown. (b) Standardized estimates and 95% confidence intervals for the association between four factors of
GAD‐7 and PHQ‐9 symptoms and age (in blue) and sex (in yellow) are shown. For age, points on the right of each panel indicate an association with
older age per 10 years and points to the left indicate an association with younger age per 10 years. For sex, points to the right of each panel
indicate an association with being female, to the left indicate an association with being male. Filled circle points indicate significant associations
while accounting for multiple testing using FDR correction. Transparent circle points indicate nonsignificant associations while accounting for
multiple testing using FDR correction. GAD‐7, Generalized Anxiety Disorder; FDR, false discovery rate; PHQ‐9, Patient Health Questionnaire
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more likely to report somatic symptoms, consistent with previous
findings (Fried et al., 2014). We found that the association between
sex and reporting somatic symptoms varied with age, contrary to
previous research which found older people were more likely to
experience somatic depression symptoms (Hegeman et al., 2012;
Schaakxs et al., 2017). Our findings show that older women were
more likely to report sleep change and younger women were more
likely to report little energy and weight/appetite problems. Sleep
problems in older adults could be partly secondary to age‐related
physical processes (Foley et al., 2004; Smagula et al., 2016), as the
circadian system, sleep homeostatic mechanisms, and sleep‐related
hormone secretion change with advancing age (Li et al., 2018). In our
study, age and sex had no association with the worry factor. How-
ever, individual symptoms loading on the worry factor differed by age
and sex: younger people reported feeling anxious and irritable,
whereas older women worried too much and had difficulty control-
ling their worrying. This replicates findings that older individuals
worry about health‐related problems (Basevitz et al., 2008; Gon-
çalves & Byrne, 2013) and worry‐related anxiety symptoms could be
enhanced by the occurrence of somatic sleep problems in older age
(Gould et al., 2016; Lenze et al., 2005). Our findings may have sub-
stantial implications for the IAPT service in the United Kingdom that
provides psychological treatment for depression and anxiety
(Griffiths & Griffiths, 2015). IAPT uses GAD‐7 and PHQ‐9 sum scores
to assess severity and ascertain which patients gain treatment.
Understanding varying age and sex presentations in GAD‐7 and PHQ‐9
could benefit decision‐making around who gains access to treatment.
Some study limitations merit acknowledgment. First, the majority
of individuals were White, female, and highly educated. This slightly
limits our interpretation of the finding that symptoms vary by sex.
However, our sample size was large and our findings are based on
more than 7000 male participants providing sufficient power to de-
tect sex differences. Nevertheless, replication is needed in more
ancestrally diverse samples (Bailey et al., 2019). Second, our analyses
were cross‐sectional and mood symptoms tend to decline over time
whereas low levels of somatic symptoms persist (Eeden et al., 2019).
Symptom profiles may vary with age and across the course of the
disorder, requiring longitudinal data to better understand this. Third,
participants reported severe levels of anxiety and depression (Davies
et al., 2019). This could suggest men taking part have more severe
symptoms due to the under‐detection and under‐reporting of milder
forms of depression and anxiety by males (Albert, 2015). Fourth, the
PHQ‐9 and GAD‐7 assess a limited range of symptoms; disorder
heterogeneity would be better captured by more detailed scales.
However, long questionnaires can lead to participant fatigue and,
hence, missing data in large samples, requiring a considered balance
TABLE 3 Age and sex‐related
variability in the four factors of
Generalized Anxiety Disorder 7‐item
(GAD‐7) and Patient Health
Questionnaire‐9 (PHQ‐9) symptoms in the
Genetic Links to Anxiety and Depression












‐ M Suicide ideation ↓ M








‐ ‐ Difficulty controlling
worrying
↑ F
Feeling anxious ↓ ‐
Feeling afraid ‐ ‐




↓ F Little energy ↓ F






↓ M Restlessness ↓ M
Motor problems ↓ M
Abbreviations: ↑, associated with greater age; ↓, associated with younger age; ‐ no association; F,
associated with being female; M, associated with being male.
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between detailed phenotyping and participating burden. Moreover,
the PHQ‐9 and GAD‐7 do not assess the direction of symptom oc-
currence. For example, somatic symptoms such as appetite or sleep
change, do not differentiate between less or greater appetite, or
more or less sleep. Thus, older individuals could experience problems
sleeping during the night, whereas younger individuals could sleep
too much (Schaakxs et al., 2017). Finally, we do not address the
multidimensionality in symptom presentations of other anxiety dis-
orders, such as panic disorder and agoraphobia. Although the GAD‐7
is considered an adequate screener for all anxiety disorders in
theIAPTservice (Beard & Björgvinsson, 2014; Clark, 2011), more re-
search is needed to explore age and sex variation in social anxiety
disorder, panic disorder, agoraphobia, social phobia, and specific
phobia with more specific questionnaires.
Our study highlights key next steps for generalized anxiety and
depression research. Rather than using sum scores, future studies
should account for symptom and factor level presentation of gen-
eralized anxiety and depression to gain an accurate reflection of
symptom profiles and individual disability. Furthermore, adopting
factors within the diagnostic framework may better represent in-
dividual burden and subsequently provide possible treatment ave-
nues. Factor‐level based scores rather than sum scores have been
shown to increase precision in treatment response trajectories
(Ballard et al., 2018). Investigating individual symptom presentation
could also provide avenues for symptom‐specific risk factors (Jokela
et al., 2019), beneficial treatment types (Boschloo et al., 2019), and
individual response to treatment (McElroy et al., 2019). For example,
mood and somatic symptoms showed larger improvement from an-
tidepressant medication compared with cognitive behavioral therapy
(Boschloo et al., 2019). Our findings have important implications for
young people, particularly young men. Not only are young men at
higher risk of depressed mood and suicide ideation (Mackenzie
et al., 2019) than women, but concentration problems and rest-
lessness that they experience can negatively impact educational at-
tainment and early career goals (Davies et al., 2018). However, our
findings were independent of the education level of our participants.
Our findings also provide avenues to better understand anxiety and
depression in later life. Many standardized tools including the GAD‐7
were designed for measurement in younger individuals (Bryant et al.,
2008). Future research that incorporates age‐appropriate symptoms
would be particularly informative for tracking the longitudinal course
of disorders and clinical use in older populations (Lenze et al., 2005).
5 | CONCLUSION
Our study provides new insights into underlying factors of general-
ized anxiety and depression symptoms. We identified four factors of
mood, worry, somatic, and motor symptoms. Individual symptom and
factor endorsement varied significantly dependent on the age and
sex of the individual. The current study supports the utilization of
individual symptoms or groups of symptoms over the commonly used
sum score approach. The results provide possible avenues for
diagnostic improvement and treatment intervention by accounting
for age‐ and sex‐related variation in symptoms of generalized anxiety
and depression.
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